Surgical Dressing Material Market Report 2026

The surgical dressing material market size has grown strongly in recent years. It will grow from $7.75 billion in 2025 to $8.33 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising number of surgical procedures, increasing prevalence of chronic wounds, growing awareness of infection prevention, expansion of healthcare facilities, advancements in wound care materials.

The surgical dressing material market size is expected to see strong growth in the next few years. It will grow to $11.25 billion by 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing demand for advanced wound management solutions, growth in home healthcare services, rising adoption of cost-effective dressing products, increasing focus on faster healing outcomes, expansion of outpatient surgical procedures. Major trends in the forecast period include increasing adoption of advanced wound care dressings, rising demand for antimicrobial and infection control dressings, growing preference for moisture-retentive dressings, expansion of home-based wound care solutions, development of multi-layer and highly absorbent dressing materials.

The growing demand for advanced wound care solutions is expected to drive the growth of the surgical dressing material market going forward. Advanced wound care solutions refer to specialized medical products and therapies designed to promote faster wound healing, minimize infection risk, and enhance patient outcomes compared to conventional wound care methods. The demand for advanced wound care solutions is increasing due to the rising incidence of chronic wounds, driven by an aging population and long-term health conditions that require continuous care. Surgical dressing materials support advanced wound care solutions by ensuring effective moisture balance, protecting against infection, and creating improved healing environments for both acute and chronic wounds. For instance, in September 2024, according to the Australian Nursing and Midwifery Journal, an Australia-based healthcare publication, approximately 450,000 Australians suffer from chronic wounds annually, costing the health and aged care system around $6.6 billion each year. Therefore, the growing demand for advanced wound care solutions is driving the growth of the surgical dressing material market.

Leading companies operating in the surgical dressing material market are focusing on developing innovative products, such as next-generation hydrofiber wound dressings, to enhance absorbency, maintain structural integrity, reduce patient discomfort, and improve healing outcomes in surgical, chronic, and acute wounds. Next-generation hydrofiber wound dressings are advanced, sterile dressings that absorb exudate, conform to the wound bed, maintain structural integrity, and support faster, undisturbed healing. For example, in July 2025, Convatec, a UK-based medical products and technologies company, announced regulatory clearance in the UK, EU, Australia, and the US for Aquacel ConvaFiber, a next-generation Hydrofiber dressing designed to manage a broad range of wounds, including venous leg ulcers, diabetic foot ulcers, pressure injuries, surgical wounds, and partial-thickness burns. The dressing is engineered using advanced Hydrofiber technology to provide high absorbency and maintain close contact with the wound surface while preserving structural integrity during use and removal. It is soft, sterile, and highly conformable, enabling effective fluid management and supporting undisturbed wound healing in both acute and community care settings. In addition, studies have shown that the dressing has a high absorption capacity compared with other gelling dressings, helping clinicians manage complex wounds more efficiently while improving patient comfort and care outcomes.

In December 2025, Solventum Corporation, a US-based healthcare solutions provider, acquired Acera Surgical for USD 725 million. Through this acquisition, Solventum intends to enhance its advanced wound care portfolio by incorporating synthetic tissue matrix technology and expanding its footprint in regenerative wound care solutions in acute care settings. Acera Surgical Inc. is a US-based bioscience company that offers fully engineered synthetic tissue matrices intended for regenerative wound care and advanced surgical dressing applications.

Major companies operating in the surgical dressing material market are Cardinal Health Inc., Medtronic plc, 3M Company, Essity Aktiebolag, Owens & Minor Inc., B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Paul Hartmann AG, ConvaTec Group plc, Hollister Incorporated, Lohmann & Rauscher GmbH & Co. KG, Zhende Medical Co. Ltd., DeRoyal Industries Inc., MiMedx Group Inc., Advanced Medical Solutions Group plc, Anika Therapeutics Inc., AlloSource, Winner Medical Co. Ltd., Urgo Medical, Dukal Corporation, Axio Biosolutions Pvt Ltd., Advancis Medical UK Ltd.

North America was the dominating region in the surgical dressing material market in 2025. Asia-Pacific is expected to be the rapidly expanding region during the forecast period. The regions covered in the surgical dressing material market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the surgical dressing material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The surgical dressing material market consists of sales of adhesive bandages, gauze dressings, surgical tapes, absorbent pads, hydrocolloid dressings, alginate dressings, foam dressings, and antimicrobial dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.